This is a preview of subscription content, log in via an institution to check access.
Reference
Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis. 1997; 24:684–703.
Pampiglione S, Manson-Bahr PE, La Placa M, Borgatti MA, Musumeci S. Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar. Trans R Soc Trop Med Hyg. 1975;69:60–68.
Carvalho EM, Barral A, Pedral-Sampaio D, Barral-Netto M, Badaró R, Rocha H, et al. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J Infect Dis. 1992;165: 535–544.
Carvalho EM. Immunoregulation in visceral leishmaniasis. In: Ozcel MA, Alkan MZ, editors. Parasitology for the 21st Century. Oxon, UK: Cab International; 1996. p. 35–39.
Gama ME, Costa JM, Gomes CM, Corbet CM. Subclinical forms of American visceral leishmaniasis. Mem Inst Oswaldo Cruz. 2004;99:889–893.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sahni, G.S. Visceral leishmaniasis (Kala-azar) without Splenomegaly. Indian Pediatr 49, 590–591 (2012). https://doi.org/10.1007/s13312-012-0105-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-012-0105-6